Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03779282 · ClinicalTrials.gov registry record
KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
A clinical trial, sponsored by Ochsner Health System.
- Completed
- Registry status
- 90
- Enrollment target
NCT03779282 is a clinical trial that has completed, run by Ochsner Health System. The registered enrollment target is 90 participants.
The verdict
NCT03779282 has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-02-15 |
| Est. Completion | 2018-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03779282
The ClinicalTrials.gov registry entry for NCT03779282 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT03779282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03779282 about?
NCT03779282 is a clinical study titled "KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery". Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we ...
What is the current status of trial NCT03779282?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2018-02-15. Estimated completion is 2018-09-15.
What interventions are being tested in trial NCT03779282?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT03779282?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.